机构:[1]Guangdong-Hong Kong Joint Laboratory for Immunological and Genetic Kidney Diseases, Departments of Nephrology and Pathology, Guangdong Provincial People’sHospital, Guangdong Academy of Medical Science, Guangzhou, China[2]Departments of Medicine & Therapeutics, Li Ka Shing Institute of Health Sciences, Lui Che WooInstitute of Innovative Medicine, and The Chinese University of Hong Kong (CUHK) - Guangdong Academy of Medical Sciences/Guangdong Provincial People’s Hospital(GAMS/GPPH) Joint Research Laboratory on Immunological and Genetic Kidney Diseases, The Chinese University of Hong Kong, Hong Kong, China[3]Hubei Universityof Chinese Medicine, Wuhan, China[4]Department of Nephrology, Hubei Provincial Hospital of Traditional Chinese Medicine, Hubei Province Academy of TraditionalChinese Medicine, Wuhan, China[5]Department of Nephrology, The Third Affiliated Hospital, Southern Medical University, Guangzhou, China
Research Grants Council
of Hong Kong (GRF 14117418, 14104019, 14101121, and R4012-18);
the High-Level Hospital Construction Project from Guangdong Provincial
People’s Hospital, Guangdong Academy of Medical Science
(KJ012019108), the Guangdong-Hong Kong-Macao-Joint Labs Program
from Guangdong Science and Technology Department (2019B121205005), the Health and Medical Research Fund of Hong
Kong (HMRF 06173986 and 07180516), and the Lui Che Woo Institute
of Innovative Medicine (CARE program).
语种:
外文
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2022]版:
大类|1 区医学
小类|1 区遗传学1 区生物工程与应用微生物1 区医学:研究与实验
最新[2025]版:
大类|1 区医学
小类|1 区生物工程与应用微生物1 区遗传学1 区医学:研究与实验
JCR分区:
出版当年[2021]版:
Q1BIOTECHNOLOGY & APPLIED MICROBIOLOGYQ1GENETICS & HEREDITYQ1MEDICINE, RESEARCH & EXPERIMENTAL
最新[2023]版:
Q1BIOTECHNOLOGY & APPLIED MICROBIOLOGYQ1GENETICS & HEREDITYQ1MEDICINE, RESEARCH & EXPERIMENTAL
第一作者机构:[1]Guangdong-Hong Kong Joint Laboratory for Immunological and Genetic Kidney Diseases, Departments of Nephrology and Pathology, Guangdong Provincial People’sHospital, Guangdong Academy of Medical Science, Guangzhou, China[2]Departments of Medicine & Therapeutics, Li Ka Shing Institute of Health Sciences, Lui Che WooInstitute of Innovative Medicine, and The Chinese University of Hong Kong (CUHK) - Guangdong Academy of Medical Sciences/Guangdong Provincial People’s Hospital(GAMS/GPPH) Joint Research Laboratory on Immunological and Genetic Kidney Diseases, The Chinese University of Hong Kong, Hong Kong, China[3]Hubei Universityof Chinese Medicine, Wuhan, China[4]Department of Nephrology, Hubei Provincial Hospital of Traditional Chinese Medicine, Hubei Province Academy of TraditionalChinese Medicine, Wuhan, China
通讯作者:
通讯机构:[1]Guangdong-Hong Kong Joint Laboratory for Immunological and Genetic Kidney Diseases, Departments of Nephrology and Pathology, Guangdong Provincial People’sHospital, Guangdong Academy of Medical Science, Guangzhou, China[2]Departments of Medicine & Therapeutics, Li Ka Shing Institute of Health Sciences, Lui Che WooInstitute of Innovative Medicine, and The Chinese University of Hong Kong (CUHK) - Guangdong Academy of Medical Sciences/Guangdong Provincial People’s Hospital(GAMS/GPPH) Joint Research Laboratory on Immunological and Genetic Kidney Diseases, The Chinese University of Hong Kong, Hong Kong, China[3]Hubei Universityof Chinese Medicine, Wuhan, China[4]Department of Nephrology, Hubei Provincial Hospital of Traditional Chinese Medicine, Hubei Province Academy of TraditionalChinese Medicine, Wuhan, China[*1]Department of Nephrology, Hubei Provincial Hospital of Traditional Chinese Medicine, Hubei Province Academy of Traditional Chinese Medicine, Wuhan, China[*2]Guangdong Academy of Medical Science, Guangdong Provincial People’s Hospital, Guangzhou, China.[*3]Departments of Medicine & Therapeutics, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, China.
推荐引用方式(GB/T 7714):
Wenjing Wu,Wenbiao Wang,Liying Liang,et al.Treatment with Quercetin inhibits SARS-CoV-2 N protein-induced acute kidney injury by blocking Smad3-dependent G1 cell cycle arrest[J].MOLECULAR THERAPY.2023,31(2):344-361.doi:10.1016/j.ymthe.2022.12.002.
APA:
Wenjing Wu,Wenbiao Wang,Liying Liang,Junzhe Chen,Biao Wei...&Hui-Yao Lan.(2023).Treatment with Quercetin inhibits SARS-CoV-2 N protein-induced acute kidney injury by blocking Smad3-dependent G1 cell cycle arrest.MOLECULAR THERAPY,31,(2)
MLA:
Wenjing Wu,et al."Treatment with Quercetin inhibits SARS-CoV-2 N protein-induced acute kidney injury by blocking Smad3-dependent G1 cell cycle arrest".MOLECULAR THERAPY 31..2(2023):344-361